Posted by
on Jun 30th, 2011 and filed under Dendreon, Apollo advance in after-hours action – MarketWatch
 Forbes (blog) |
Dendreon, Apollo advance in after-hours action
MarketWatch LOS ANGELES (MarketWatch) — Dendreon Corp. shares rose late Thursday as a cancer drug from the company received approval for coverage by Medicare, and Apollo Group Inc. shares jumped after the for-profit education company's … Medicare Will Pay for Prostate Cancer Drug Full Steam Ahead for Dendreon Dendreon Wins Final Medicare Coverage Decision on Prostate Cancer Drug |
